Abstract
Objective
To investigate the predictive value of the ratio of homocysteine to serum albumin concentrations (Hcy/Alb) in the recurrence of diabetic foot ulcer (DFU).
Methods
A total of 210 patients hospitalized due to diabetic foot disease from May 2012, to May 2017 were selected and followed up for one year. The value of Hcy/Alb in predicting the recurrence of DFU was determined using receiver operating characteristic (ROC) curve analysis.
Results
Hcy (odd ratio = 1.171; 95% confidence interval (CI) 1.101–1.246) was an independent risk factor for the recurrence of DFU. Alb (odd ratio = 0.848; 95% CI 0.792–0.908) was a protective factor for the recurrence of DFU. The area under the ROC curve of Hcy/Alb for predicting the recurrence of DFU was 0.803 (95% CI 0.742–0.864; p < 0.01). When the Hcy/Alb was set at the best cutoff value (0.37), its sensitivity in predicting the recurrence of DFU was 97.60%, and the negative predictive value was 98.93%.
Conclusions
The sensitivity and negative predictive value of Hcy/Alb in predicting the recurrence of DFU and the overall coincidence rate are high.
Similar content being viewed by others
References
Boulton AJ. The diabetic foot: a global view. Diabetes Metab Res Rev. 2000;16:S2–5.
Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T. Health-related quality of life among patients with diabetes and foot ulcers: association with demographic and clinical characteristics. J Diabetes Complicat. 2007;21:227–36.
Anichini R, Zecchini F, Cerretini I, Meucci G, Fusilli D, Alviggi L, et al. Improvement of diabetic foot care after the implementation of the international consensus on the diabetic foot (ICDF): results of a 5-year prospective study. Diabetes Res Clin Pract. 2007;75:153–8.
Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K; International Working Group on the Diabetic Foot. Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents. Diabetes Metab Res Rev 2016;321:7–15.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.
Waaijman R, de Haart M, Arts ML, Wever D, Verlouw AJ, Nollet F, et al. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients. Diabetes Care. 2014;37:1697–705.
Winkley K, Stahl D, Chalder T, Edmonds ME, Ismail K. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabet Complicat. 2007;21:341–9.
Rankin TM, Miller JD, Gruessner AC, Nickerson DS. Illustration of cost saving implications of lower extremity nerve decompression to prevent recurrence of diabetic foot ulceration. J Diabetes Sci Technol. 2015;9:873–80.
Škovierová H, Vidomanová E, Mahmood S, Sopková J, Drgová A, Červeňová T, et al. The molecular and cellular effect of homocysteine metabolism imbalance on human health. Int J Mol Sci. 2016;17:1733.
Mao X, Xing X, Xu R, Gong Q, He Y, Li S, et al. Folic acid and vitamins D and B12 correlate with homocysteine in Chinese patients with type-2 diabetes mellitus, hypertension, or cardiovascular disease. Medicine (Baltimore). 2016;95:e2652.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.
Boulton AJ. Foot problems in patients with diabetes mellitus. In: Pickup WG, editor. Texabook lf diabetes. 2th ed. London: Blackwell; 1997. p. 1.
Connor H, Mahdi OZ. Repetitive ulceration in neuropathic patients. Diabetes Metab Res Rev. 2004;20:S23–8.
Jung S, Je Y, Giovannucci EL, Rosner B, Ogino S, Cho E. Derivation and validation of homocysteine score in U.S. men and women. J Nutr. 2015;145:96–104.
Liu Z, Luo Y, Jeppesen PB, Gregersen S, Hermansen K. Amino acid-induced gene expression profiling in clonal β-cell line INS-1E cells. Diabetes Metab Res Rev. 2011;27:120–76.
Weber GJ, Pushpakumar S, Tyagi SC, Sen U. Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. Pharmacol Res. 2016;113:300–12.
Srivastav K, Saxena S, Mahdi AA, Shukla RK, Meyer CH, Akduman L, et al. Increased serum level of homocysteine correlates with retinal nerve fiber layer thinning in diabetic retinopathy. Mol Vis. 2016;22:1352–60.
Satyanarayana A, Balakrishna N, Pitla S, Reddy PY, Mudili S, Lopamudra P, et al. Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLoS One. 2011;6:e26747.
Mao S, Xiang W, Huang S, Zhang A. Association between homocysteine stats and the risk of nephropathy in type 2 diabetes mellitus. Clin Chim Acta. 2014;431:206–10.
Gazzaruso C, Coppola A, Montalcini T, Baffero E, Garzaniti A, Pelissero G, et al. Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine. 2012;41:89–95.
Jun JE, Lee SE, Lee YB, Jee JH, Bae JC, Jin SM, et al. Increase in serum albumin concentration is associated with prediabetes development and progression to overt diabetes independently of metabolic syndrome. PLoS One. 2017;12:e0176209.
Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319–34.
An JS, Zhao J, Wang XY. Risk factors of severe diabetic foot ulcer and amputations. Chin Gen Pract. 2017;11:37–44.
Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World J Diabetes. 2015;6:37–53.
De Crée C, Malinow MR, van Kranenburg GP, Geurten PG, Longford NT, Keizer HA. Infuluence of exercise and menstrual cycle phase on plasma homocysteine levels in young women-a prospective study. Scand J Med Sci Sports. 1999;9:272–8.
Samman S, Sivarajah G, Man JC, Ahmad ZI, Petocz P, Caterson ID. A mixed fruit and vegetable concent rate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr. 2003;133:2188–93.
Cotlarciuc I, Andrew T, Dew T, Clement G, Gill R, Surdulescu G, et al. The basis of differential responses to folic acid supplementation. J Nutrigenet Nutrigenomics. 2011;4:99–109.
Markuson M, Hanson D, Anderson J, Langemo D, Hunter S, Thompson P, et al. The relationship between hemoglobin A1C values and healing time for lower extremity ulcers in individuals with diabetes. Adv Skin Wound Care. 2009;22:365–72.
Feng SH, Wang PH, Zhu YJ. Patients with diabetic foot infection pathogenic bacteria distribution and drug resistance analysis. Chin J Diabetes. 2009;17:293–5.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Ethics Committee of Jinzhou Central Hospital, No. 2018-NFM-021) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
An, J., Yu, H., Gao, Z. et al. Predictive value of the ratio of homocysteine to serum albumin concentrations in the recurrence of diabetic foot ulcer. Int J Diabetes Dev Ctries 39, 667–672 (2019). https://doi.org/10.1007/s13410-019-00744-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-019-00744-z